News and Announcements
Bulletproof Group Appoints New Chief Financial Officer
- Published April 21, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Bulletproof Group Limited (ASX:BPF) (Bulletproof) is pleased to advise that Paula Kensington FCCA has been appointed to commence as the company’s Chief Financial Officer (CFO), effective 1 May 2017.
KEY TAKEAWAYS:
- Ms. Kensington has in depth experience in software business, specifically as the CFO and Company Secretary of Rubik Financial Limited (ASC: RFL). During her role there, Ms. Kensington took an active role in driving the company’s high growth period through acquisitions and organic transformation.
- Recently, she was the joint CFO and COO of Regus Australia & New Zealand, which included oversight of acquisition and integration of 11 new business centres.
- During 2013, Ms. Kensington was awarded the Thomson Reuters CFO of the Year award, recognising the transformation and significant growth in enterprise value that she bought to Rubik Financial Limited.
Bulletproof CEO, Anthony Woodward, said, “We are excited to have Ms. Kensington working with us as the company moves though its transition phase into a period of sustainable top and bottom line growth, where her extensive experience in building and enhancing financial systems and processes through both a financial and operational lens will be invaluable.”
Founded in 2000, Bulletproof is Australia’s leading cloud services company, supporting business, enterprise and government customers across the globe. Bulletproof has consistently been first to market with public and private cloud based services and innovations. With over a decade of experience in cloud, Bulletproof continues to drive industry innovation.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
